140 related articles for article (PubMed ID: 12900756)
1. DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection.
Perlstein I; Connolly JM; Cui X; Song C; Li Q; Jones PL; Lu Z; DeFelice S; Klugherz B; Wilensky R; Levy RJ
Gene Ther; 2003 Aug; 10(17):1420-8. PubMed ID: 12900756
[TBL] [Abstract][Full Text] [Related]
2. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling.
Chapados R; Abe K; Ihida-Stansbury K; McKean D; Gates AT; Kern M; Merklinger S; Elliott J; Plant A; Shimokawa H; Jones PL
Circ Res; 2006 Oct; 99(8):837-44. PubMed ID: 16990566
[TBL] [Abstract][Full Text] [Related]
3. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus.
Klugherz BD; Song C; DeFelice S; Cui X; Lu Z; Connolly J; Hinson JT; Wilensky RL; Levy RJ
Hum Gene Ther; 2002 Feb; 13(3):443-54. PubMed ID: 11860711
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery from a DNA controlled-release stent in porcine coronary arteries.
Klugherz BD; Jones PL; Cui X; Chen W; Meneveau NF; DeFelice S; Connolly J; Wilensky RL; Levy RJ
Nat Biotechnol; 2000 Nov; 18(11):1181-4. PubMed ID: 11062438
[TBL] [Abstract][Full Text] [Related]
5. Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent.
Takahashi A; Palmer-Opolski M; Smith RC; Walsh K
Gene Ther; 2003 Aug; 10(17):1471-8. PubMed ID: 12900762
[TBL] [Abstract][Full Text] [Related]
6. Immobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapy.
Jin X; Mei L; Song C; Liu L; Leng X; Sun H; Kong D; Levy RJ
J Gene Med; 2008 Apr; 10(4):421-9. PubMed ID: 18213735
[TBL] [Abstract][Full Text] [Related]
7. Regulation of vascular smooth muscle cells by micropatterning.
Thakar RG; Ho F; Huang NF; Liepmann D; Li S
Biochem Biophys Res Commun; 2003 Aug; 307(4):883-90. PubMed ID: 12878194
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.
Jones PL; Crack J; Rabinovitch M
J Cell Biol; 1997 Oct; 139(1):279-93. PubMed ID: 9314546
[TBL] [Abstract][Full Text] [Related]
9. Gene transduction into aortic wall using plasmid-loaded cationized gelatin hydrogel-coated polyester stent graft.
Zhong H; Matsui O; Xu K; Ogi T; Sanada J; Okamoto Y; Tabata Y; Takuwa Y
J Vasc Surg; 2009 Dec; 50(6):1433-43. PubMed ID: 19782523
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents.
Pan ChJ; Tang JJ; Weng YJ; Wang J; Huang N
J Control Release; 2006 Nov; 116(1):42-9. PubMed ID: 17046093
[TBL] [Abstract][Full Text] [Related]
11. Identification of integrins involved in cell adhesion to native and denatured type I collagens and the phenotypic transition of rabbit arterial smooth muscle cells.
Yamamoto M; Yamato M; Aoyagi M; Yamamoto K
Exp Cell Res; 1995 Jul; 219(1):249-56. PubMed ID: 7628540
[TBL] [Abstract][Full Text] [Related]
12. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents.
Brito LA; Chandrasekhar S; Little SR; Amiji MM
J Biomed Mater Res A; 2010 Apr; 93(1):325-36. PubMed ID: 19569206
[TBL] [Abstract][Full Text] [Related]
14. [A novel anti-DNA antibody modified coronary stent for site-specific plasmid DNA delivery].
Jin X; Leng XG; Liu LX; Gu HG; Zhang C; Wang H; Song CX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):665-9. PubMed ID: 17121228
[TBL] [Abstract][Full Text] [Related]
15. Matrix-protein-specific regulation of Cx43 expression in cardiac myocytes subjected to mechanical load.
Shanker AJ; Yamada K; Green KG; Yamada KA; Saffitz JE
Circ Res; 2005 Mar; 96(5):558-66. PubMed ID: 15705967
[TBL] [Abstract][Full Text] [Related]
16. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle.
Labhasetwar V; Bonadio J; Goldstein S; Chen W; Levy RJ
J Pharm Sci; 1998 Nov; 87(11):1347-50. PubMed ID: 9811488
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
18. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds.
Huang YC; Riddle K; Rice KG; Mooney DJ
Hum Gene Ther; 2005 May; 16(5):609-17. PubMed ID: 15916485
[TBL] [Abstract][Full Text] [Related]
19. beta1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal alpha-actin promoter.
Wei L; Wang L; Carson JA; Agan JE; Imanaka-Yoshida K; Schwartz RJ
FASEB J; 2001 Mar; 15(3):785-96. PubMed ID: 11259397
[TBL] [Abstract][Full Text] [Related]
20. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
